The Ministry of Health, in collaboration with the World Health Organization (WHO), has been conducting advanced clinical studies in seven different centers at the several hospitals across the Kingdom to combat novel coronavirus. The process have been launched at King Faisal Specialist Hospital, at the Medical City of King Saud University, at Prince Mohammed Bin Abdulaziz Hospital, all in Riyadh, at Uhud Hospital in Madinah, at Nur Hospital in Makkah as well as at Dammam Central Hospital and Qatif Central Hospital, in the Eastern Region. The medical team, comprising physicians, pharmacists and researchers are aiming at assessing four remedy protocols that include Hydroxychloroquine lopinavir/Ritonavir Remedisivir Interferon. These drugs have anti-viral properties or imitate some of virus immunity response techniques and are given orally or through the vein. The study is focusing on those showing medium to strong symptoms and that these drugs have proven preliminary effectiveness during the laboratory studies. Launching the study on Saturday was asserted by the General Department for Research and Studies, as some who have been contracting the virus were admitted as patients, simultaneously, at the beginning of the clinical experiment. The project shed light on the limitless efforts exerted by the government of Saudi Arabia and full support of Custodian of the Two Holy Mosques King Salman and Crown Prince Muhammad Bin Salman, as they spare no endeavor to find effective vaccine to the pandemic, to maintain the safety and hygiene of citizens and residents, living on the motherland soils. — SPA
